搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
5 小时
on MSN
23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
The Pharma Letter
1 分钟
23andMe cuts workforce and abandons drug development
Me is restructuring, cutting 40% of its workforce, ending its therapeutics programs, and refocusing on its consumer genetics ...
9 小时
on MSN
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...
3 小时
23andMe Slashes Workforce By 40%, Ends Therapeutic Programs
The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.
10 小时
on MSN
23andMe cuts 40% of its workforce, discontinues all therapy programs
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing ...
6 小时
on MSN
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...
pharmaphorum
2 小时
23andMe ends drug development and slashes staff
Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...
8 小时
DNA-testing site 23andMe to lay off 40% of its workers
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
STAT
1 天
The end of 23andMe’s drug discovery dream
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...
FierceBiotech
13 小时
23andMe shutters cancer drug research programs, lays off 40% of staff
23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...
ENDPOINTS NEWS
10 小时
23andMe to shut down its therapeutics division
Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...
newsbytesapp.com
3 小时
DNA-testing site 23andMe is slashing its workforce by 40%
23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees, or nearly 40% of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈